(19)
(11)
EP 0 837 864 A1
(12)
(43)
Date of publication:
29.04.1998
Bulletin 1998/18
(21)
Application number:
96924829.0
(22)
Date of filing:
01.07.1996
(51)
International Patent Classification (IPC):
A61K
31/
675
( . )
A61P
9/
10
( . )
C07D
241/
44
( . )
A61P
9/
00
( . )
A61P
25/
08
( . )
C07F
9/
6509
( . )
(86)
International application number:
PCT/EP1996/002866
(87)
International publication number:
WO 1997/003079
(
30.01.1997
Gazette 1997/06)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
SI
(30)
Priority:
10.07.1995
CH 19950002009
(71)
Applicant:
Novartis AG
4058 Basel (CH)
(72)
Inventors:
MORETTI, Robert
CH-1627 Vaulruz (CH)
ALLGEIER, Hans
D-79541 Lörrach (DE)
(74)
Representative:
Roth, Bernhard M., et al
Novartis AG Geistiges Eigentum Konzern
4002 Basel
4002 Basel (CH)
(54)
NOVEL QUINOXALINE- AND QUINOXALINYLALKANE-PHOSPHONIC ACIDS